-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Vaxcyte, Raises Price Target to $125

Benzinga·10/05/2026 12:53:26
Listen to the news
Guggenheim analyst Seamus Fernandez maintains Vaxcyte (NASDAQ:PCVX) with a Buy and raises the price target from $116 to $125.